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Introduction {#sec006}
============

Cystic fibrosis, caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR), is characterized by defective Cl^-^ and HCO~3~^-^ epithelial ion transport. In the airways this results in thick, sticky mucus, impairing airway surface liquid (ASL) height and mucociliary clearance (MCC). In healthy individuals, routine microbial insults of the lung are cleared through a non-pathologic inflammatory response, coupled with bronchotracheal MCC of mucus-trapped pathogens, thereby preventing obstruction and infection \[[@pone.0189894.ref001]\]. In cystic fibrosis (CF), defective MCC leads to bronchiectasis, chronic infections, and progressive loss of lung function. Bronchotracheal Cl^-^ and HCO~3~^-^ secretion contribute to ASL height and MCC through effects on extracellular hydration and mucin expansion \[[@pone.0189894.ref002]--[@pone.0189894.ref004]\]. In the model put forth by Haq *et al*., defective Cl^-^ and HCO~3~^-^ transport in CF leads to a dehydrated and acidic ASL. Dysregulation of the epithelial Na^+^ channel (ENaC) causes Na^+^ hyperabsorption, further dehydrating the ASL layer. Water moves out of the mucus layer and eventually out of the periciliary layer, which coupled with increases mucus viscosity due to the acidic environment, results in a thick, viscous layer that compresses the cilia and impairs MCC \[[@pone.0189894.ref005]\].

Airway anion secretion occurs in response to microbial infection \[[@pone.0189894.ref006]\] and inflammatory mediators. In infected airways, prostaglandin E~2~ (PGE~2~) is abundantly produced by epithelia and infiltrating inflammatory cells, and is found in bronchioalveolar lavage fluid, sputum, and airway epithelium \[[@pone.0189894.ref007]--[@pone.0189894.ref010]\]. During acute CF pulmonary exacerbations, sputum PGE~2~ levels can increase over four-fold \[[@pone.0189894.ref009]\]. In the intestines, PGE~2~ stimulates Cl^-^, HCO~3~^-^, and mucin secretion *via* cAMP, Ca^2+^, and PI3K (phosphatidylinositol 3-kinase) signaling \[[@pone.0189894.ref011], [@pone.0189894.ref012]\]. In the duodenum CFTR is an important HCO~3~^-^ exit pathway for PGE~2~-stimulated HCO~3~^-^ secretion, but unlike many other stimuli, PGE~2~ may also stimulate HCO~3~^-^ secretion through CFTR-independent exit pathways \[[@pone.0189894.ref013], [@pone.0189894.ref014]\]. In the airways, PGE~2~ has been shown to increase iodide transport and short-circuit current (*I*~*sc*~), which has led to a presupposition that PGE~2~ stimulates anion transport through CFTR \[[@pone.0189894.ref015]--[@pone.0189894.ref017]\], however, its specific role in Cl^-^ and HCO~3~^-^ secretion in CF airways remains unclear.

We hypothesized that PGE~2~ signaling plays an important role in the normal response to airway insult by activating, *via* CFTR, Cl^-^ and HCO~3~^-^ dependent fluid secretion that optimizes mucus clearance, and that in CF, defective PGE~2~-stimulated anion secretion contributes to CF airway disease. In order to specifically study Cl^-^ *vs*. HCO~3~^-^ transport, we crafted a series of experiments that promoted preferential transport of Cl^-^ *vs*. HCO~3~^-^, performed ion substitution studies, and used pH-stat titration for measurement of HCO~3~^-^ secretion. We studied this process in cell culture models of bronchial surface epithelial cells, submucosal glandular cells, and intact trachea to determine the effects of PGE~2~ on Cl^-^ and HCO~3~^-^ secretion in distinct components of the airway, and assessed how these components may contribute to MCC.

Materials and methods {#sec007}
=====================

Cell culture and tissues {#sec008}
------------------------

16HBE14o-, CFBE41o- + wildtype CFTR (CFBE41 WT), CFBE41o- + homozygous F508del CFTR (CFBE41 CF), and Calu-3 cell lines were cultured using procedures similar to previously, according to standard protocols \[[@pone.0189894.ref018]--[@pone.0189894.ref020]\]. Primary cultures from human bronchial epithelial cells and CF nasal polyp explant epithelial cells were obtained from Dr. Walter Finkbeiner (University of California, San Francisco) and were cultured using published protocols \[[@pone.0189894.ref021], [@pone.0189894.ref022]\]. Calu-3 cells were purchased from ATCC (Manassas, VA). All cells were grown at air-liquid interface and used when transepithelial resistance indicated intact monolayer. Calu-3 cells were used at about 300Ω.cm^2^ and bronchial epithelial cell lines at about 1000Ω.cm^2^. *Mustela putorius* ferrets of 6--36 months old were obtained 1--2 hours postmortem by pentobarbital sodium injection and tissues were transported in ice-cold PhysioSol^TM^ (Hospira, IL) solution. Trachea was obtained from just below the larynx to just above the carina. Tissues were transferred to ice-cold Krebs Ringer HCO~3~^-^-buffered solution and gassed with 95% O~2~/5% CO~2~ until used, usually within 6 hours of procurement \[[@pone.0189894.ref002]\]. All protocols for handling animal tissues at Stanford were approved by the Administrative Panel on Laboratory Animal Care (Stanford's Institutional Animal Care and Use Committee: IACUC protocol\#: 10048).

Mucociliary clearance {#sec009}
---------------------

Experiments were performed in a manner similar to that done previously \[[@pone.0189894.ref002]\]. The dorsal muscular portion of the trachea was cut along its entire length and the opened trachea with cartilage intact was pinned mucosal side up in a chamber allowing the serosal side to be bathed in a 37°C Kreb's Ringer HCO~3~^-^-buffered solution with indomethacin (1 μM). The mucosal side was exposed to warm, humidified air (95% O~2~/5% CO~2~). Mounted trachea was stabilized in the chamber for 15 minutes, except when pretreated with CFTR~inh~-172 inhibitor, and then the bath was discarded and replaced with fresh solution. For CFTR inhibitor studies, the trachea was bathed bilaterally with CFTR~inh~-172 (20 μM) for 30 minutes and then CFTR~inh~-172 remained in the serosal bath for the entire experiment. Xerox ink particles were deposited at the proximal portion of the trachea and a video camera captured images every 20 seconds, tracking the particles as they moved towards the distal end. Measurements (mm/min) were averaged over 5 minutes and tracked for 30 minutes. Tissue viability was tested at the end of each experiment with forskolin (10 μM) and carbachol (0.3 μM).

Measurement of *I*~*sc*~ {#sec010}
------------------------

Snapwell inserts with confluent cell culture monolayers were mounted in an Ussing chamber (Physiologic Instruments P2300), and transepithelial voltage was clamped to zero millivolts using a voltage clamp meter (Physiologic Instruments VCC600), and *I*~*sc*~ recorded on a computer using data acquisition software (LabChart 8, ADInstruments). To monitor changes in transepithelial resistance, a voltage pulse of 1 mV was applied every 60 seconds with measurement of resultant deflections of *I*~*sc*~. Ohm's Law was used to calculate transepithelial resistance. Ussing chambers were kept at 37°C with a temperature-controlled water bath circulator and both mucosal and serosal solutions were continuously gassed with 95% O~2~/5% CO~2~. For HCO~3~^-^-free experiments mucosal and serosal solutions were gassed with 100% O~2~. All snapwells were rinsed in unbuffered HCO~3~^-^-free solution prior to placement in Ussing chambers. For tracheal tissues, the tissue was placed in ice-cold PhysioSol^TM^ (Hospira, IL) solution until further dissection, at which time it was placed in solution containing indomethacin (10 μM) to inhibit endogenous prostaglandin release due to dissection trauma. The tracheal submucosal layer containing cartilage was left intact, however, the outer layer covering the cartilage was bluntly dissected under a dissecting microscope with transillumination to ensure no over dissection. Tissue was bathed in indomethacin-containing solution during the entire dissection. Tissues were secured in sliders with steel pins, which are located sufficient distance away from the aperture so as not to interfere with ion transport measurements. Indomethacin (10 μM, bilaterally) was present during Ussing chamber experiments to prevent *de novo* formation of prostaglandins. Amiloride (10 μM, mucosal), to inhibit epithelial Na^+^ channel (ENaC), was added at the beginning of the experiment and was present throughout the entire experiment. For CFTR~inh~-172 pre-treatment, CFTR~inh~-172 (20 μM, mucosal) was added at least 30 minutes prior to PGE~2~ stimulation. For HCO~3~^-^-free experiments, acetazolamide (300 μM, bilateral) was used to inhibit carbonic anhydrase, in addition to O~2~ gassing and HCO~3~^-^ removal from solutions.

Measurement of HCO~3~^-^ secretion by pH-stat {#sec011}
---------------------------------------------

The pH-stat method, which measures the amount of HCl needed to keep the luminal bath at a constant pH using a pH electrode, was used to measure HCO~3~^-^ secretion. Automatic titrators (Metrohm Titrando 902) were used to titrate 0.2 μL aliquots of 5 mM HCl into the mucosal bath at a steady rate in order to keep from under- or overshooting the set pH. The pH was set to 6.9 in order to prevent activation of apical HCVN1 proton channels which are activated at pH \>7.0 \[[@pone.0189894.ref023]\]. Tiamo software (Metrohm) was used to control the rate of titration and continuously measure the amount titrated and pH. Bicarbonate secretory rates (μmol.cm^2^.h^-1^) were calculated in 5 minute intervals by noting the amount titrated, the concentration of titrant, and the surface area of the slider aperture. Short-circuit measurements were simultaneously performed during pH-stat measurements in a similar manner as Cl^-^ secretion measurements, with a few exceptions. First, cell monolayers were not voltage pulsed. To monitor transepithelial resistance, the voltage clamp was released and the open circuit voltage was recorded every 10 minutes. During this time the auto-titrator was briefly paused to ensure no interference. Second, the serosal solution was bathed with 95% O~2~/5% CO~2~ (similar to Cl^-^ experiments), but the mucosal solution was bathed with 100% O~2~ to prevent base formation from carbonhic anhydrase conversion of CO~2~.

Solutions {#sec012}
---------

The Krebs Ringer HCO~3~^-^-buffered solution for MCC consisted of (in mM): NaCl 115, K~2~HPO~4~ 2.4, KH~2~PO~4~ 0.4, NaHCO~3~ 25, MgCl~2~ 1.2, CaCl~2~ 1.2, Glucose 10. Solutions for tracheal Ussing chamber experiments consisted of the following in mM. Mucosal: NaGluconate 115, K~2~HPO~4~ 2.4, KH~2~PO~4~ 0.4, NaHCO~3~ 25, Mg(Gluconate)~2~ 1.2, Ca(Gluconate)~2~ 4, Mannitol 10; Serosal: NaCl 115, K~2~HPO~4~ 2.4, KH~2~PO~4~ 0.4, NaHCO~3~ 25, MgCl~2~ 1.2, CaCl~2~ 1.2, Glucose 10. For Cl^-^ secretion experiments with human bronchial epithelial cells and Calu-3 cells, solutions were as following in mM: Mucosal: NaGluconate 120, NaHCO~3~ 25, KH~2~PO~4~ 3.3, K~2~HPO~4~ 0.8, Ca(Gluconate)~2~ 4, Mg(Gluconate)~2~ 1.2, Mannitol 10; Serosal: NaCl 120, NaHCO~3~ 25, KH~2~PO~4~ 3.3, K~2~HPO~4~ 0.8, CaCl~2~ 1.2, MgCl~2~ 1.2, Glucose 10. For HCO~3~^-^ secretion measurements by *I*~*sc*~ only, solutions were similar to the above, except (in mM): Mucosal: NaCl 120, NaHEPES 25. For pH-stat experiments, solutions were as follows (in mM): Mucosal: NaCl 115, NaGluconate 25, KCl 5, CaCl~2~ 1.2, MgCl~2~ 1.2, Mannitol 10; Serosal: NaCl 120, NaHCO~3~ 25, KH~2~PO~4~ 3.3, K~2~HPO~4~ 0.8, CaCl~2~ 1.2, MgCl~2~ 1.2, Glucose 10. All solutions had an osmolarity of approximately 290 mOsm, as determined by a vapor pressure osmometer (Wescor, 5500).

Inhibitors {#sec013}
----------

As stated above, CFTR~inh~-172 (20 μM, mucosal) was used to inhibit CFTR \[[@pone.0189894.ref024]\], amiloride (10 μM, mucosal) to inhibit ENaC, acetazolamide (300 μM, bilaterally) to inhibit carbonic anhydrase, and indomethacin (10 μM, bilaterally) to inhibit prostaglandin formation *via* cycloxygenase. Additionally, bumetanide (10 μM, serosal) was used to inhibit the basolateral Na^+^:K^+^/2Cl^-^ (NKCC) channel and niflumic acid (100 μM, mucosal) to inhibit Ca^2+^-activated Cl^-^ channels. Oubain (10 μM, mucosal) was used to inhibit apical non-gastric H^+^/K^+^ ATPase. All drugs (inhibitors plus PGE~2~, forskolin, carbachol, adenosine-triphosphate (ATP)) were obtained from Sigma-Aldrich.

Statistical analysis {#sec014}
--------------------

Mean ± standard error of the mean (SEM) were calculated for all experiments with at least three replicates. Statistical significance between groups was determined using paired and unpaired Student's t-test, as appropriate. Time course comparisons were performed using one-way analysis of variance (ANOVA). Significance was determined at P values \< 0.05.

Results {#sec015}
=======

Mucociliary clearance {#sec016}
---------------------

We first examined the effect of PGE~2~ on MCC, with a validated model of MCC using ferret trachea *ex vivo* \[[@pone.0189894.ref002]\]. Serosal exposure of PGE~2~ in concentrations ranging from 10^−7^ M to 10^−5^ M (n = 3 each dose), produced a dose-dependent increase in MCC with an EC~50~ of 0.82 μM ([Fig 1A](#pone.0189894.g001){ref-type="fig"}). In examining the timecourse of stimulation, PGE~2~ (1 μM, serosal) increased MCC with an initial peak at 5 minutes, followed by a lower sustained response (n ≥ 6 each). Pre-treatment with CFTR~inh~-172 (20 μM; n ≥ 6 each) attenuated the initial peak (P \< 0.05), but did not affect the sustained plateau ([Fig 1B](#pone.0189894.g001){ref-type="fig"}). These data suggest that PGE~2~-stimulated MCC is partially CFTR-dependent, and may contain a CFTR-independent mechanism for clearance.

![PGE~2~-stimulated mucociliary transport in ferret trachea.\
**A.** PGE~2~ stimulates a dose-dependent increase in MCC in ferret trachea. Each tissue was exposed to 2--3 doses of PGE~2~ for 30 minutes each (n = 3 each dose). Data are shown as the mean PGE~2~-stimulated increase in MCC over baseline ± SEM. The half-maximal effective concentration (EC~50~) is noted in lower right corner. **B.** Timecourse of PGE~2~-stimulated MCC with and without CFTR inhibition (n ≥ 6 each). For CFTR inhibition, tissues were bathed in apical and serosal solution for 30 minutes with CFTR~inh~-172 (20 μM) prior to the 15-minute period and kept in the serosal bath for the length of the experiment. PGE~2~ (1 μM) was added to the serosal bath. Circles represent means with bars indicating SEM. Asterisks represent P \< 0.05 by ANOVA.](pone.0189894.g001){#pone.0189894.g001}

Cl^-^ secretion {#sec017}
---------------

Ferret tracheal MCC has been shown to be highly dependent on transepithelial Cl^-^ transport \[[@pone.0189894.ref002]\]. Thus, to correlate PGE~2~-stimulated MCC rate to Cl^-^ transport, we examined PGE~2~-stimulated *I*~*sc*~ with ferret trachea mounted in Ussing chambers with a serosal to mucosal Cl^-^ gradient. As seen in [Fig 2A](#pone.0189894.g002){ref-type="fig"}, in the presence of amiloride (10 μM, mucosal), PGE~2~ (1 μM, serosal) stimulated a significant increase in *I*~*sc*~ over baseline (65.83 ± 12.01 *vs*. 78.61 ± 14.43 μA/cm^2^, P \< 0.01, n = 7). Subsequent addition of CFTR~inh~-172 (20 μM, mucosal) caused a significant, but not complete, inhibition of PGE~2~-stimulated *I*~*sc*~ (PGE~2~: 76.75 ± 14.24 *vs*. CFTR~inh~-172: 69.90 ± 13.82 μA/cm^2^, P \< 0.01, n = 7) ([Fig 2A and 2C](#pone.0189894.g002){ref-type="fig"}). Further addition of bumetanide (10 μM, serosal) to block basolateral Cl^-^ uptake *via* NKCC, completely abolished the remaining PGE~2~-stimulated *I*~*sc*~ (-10.23 ± 4.33 ΔμA/cm^2^ from baseline, n = 7). These results show that: 1) PGE~2~-stimulated *I*~*sc*~ is reflective of transepithelial Cl^-^ secretion, and 2) CFTR is responsible for the majority, but not all, of PGE~2~-stimulated Cl^-^ secretion. With the ability of PGE~2~ to stimulate cAMP and Ca^2+^ intracellular signaling pathways, we next examined if the remaining bumetanide-sensitive *I*~*sc*~ was from activation of Ca^2+^-activated Cl^-^ channels. In similar experiments, we examined the ability of niflumic acid (NFA: 100 μM, mucosal), a Ca^2+^-activated Cl^-^ channel inhibitor, to inhibit CFTR-independent *I*~*sc*~. In these experiments tissues were pre-treated with amiloride (10 μM, mucosal) and CFTR~inh~-172 (20 μM, mucosal) for at least 30 minutes prior to PGE~2~ stimulation. [Fig 2B and 2C](#pone.0189894.g002){ref-type="fig"} show that NFA eliminates PGE~2~-stimulated *I*~*sc*~ in the presence of CFTR~inh~-172 (Baseline: 62.93 ± 8.58 *vs*. NFA: 60.22 ± 8.11 μA/cm^2^, n = 5), suggesting that Ca^2+^-activated Cl^-^ channels may be responsible for CFTR-independent PGE~2~-stimulated Cl^-^ secretion in ferret trachea.

![In ferret trachea, PGE~2~ stimulated *I*~*sc*~ is mediated by CFTR and Ca^2+^-activated Cl^-^ channels.\
**A.** Representative *I*~*sc*~ trace with vertical deflections indicating the change in *I*~*sc*~ after a 1 mV pulse was applied (every 1 minute). Ferret trachea was exposed to serosal to mucosal Cl^-^ gradient with equivalent bilateral HCO~3~^-^. PGE~2~ (1 μM, serosal) was added to ferret trachea after a baseline period of ≥ 10 minutes, with CFTR~inh~-172 (20 μM, mucosal) added after 30 minutes. **B.** Representative *I*~*sc*~ trace of ferret trachea incubated in CFTR~inh~-172 (20 μM, mucosal) for at least 30 minutes prior to PGE~2~ (1 μM, serosal) stimulation. After 30 minutes, niflumic acid (100 μM, mucosal) was added. **C.** Change in PGE~2~-stimulated *I*~*sc*~ (mean ± SEM, n ≥ 5) in ferret trachea, with comparisons between no inhibition, CFTR inhibition, or CFTR and Ca^2+^-activated Cl^-^ inhibition. Asterisks denote significance by Student's t-test (\*, P \< 0.05, \*\*, P \< 0.01). Mean percent inhibition compared to PGE~2~ stimulation alone noted.](pone.0189894.g002){#pone.0189894.g002}

Since airway fluid is composed of secretions from both surface epithelial cells and submucosal glands, we next examined the individual contributions from cell culture models of bronchial epithelial cells and serous gland cells. We first examined PGE~2~-stimulated *I*~*sc*~ in CFBE41o- with transfected wildtype CFTR (CFBE41 WT) and with transfected F508del CFTR (CFBE41 CF) as models of surface epithelial cells. In the presence of amiloride (10 μM, mucosal), PGE~2~ (1 μM, serosal) stimulated a rapid and significant increase in *I*~*sc*~ over baseline in CFBE41 WT cells (47.84 ± 12.02 *vs*. 120.67 ± 4.75 μA/cm^2^, P \< 0.01, n = 4). This response was completely abolished with CFTR~inh~-172 (20 μM, mucosal) (-41.47 ± 11.98 ΔμA/cm^2^ from baseline, n = 4). Given the magnitude of this inhibition, to ensure cells were still viable, ATP (500 μM, mucosal) was added after CFTR~inh~-172. ATP produced a rapid and transient increase in *I*~*sc*~ ([Fig 3A](#pone.0189894.g003){ref-type="fig"}). Similar experiments were performed with CFBE41 CF cells, which have little to no CFTR activity. In these cells PGE~2~ (1 μM, serosal) failed to stimulate *I*~*sc*~ (6.79 ± 1.69 *vs*. 5.84 ± 1.20 μA/cm^2^, P \> 0.05, n = 5). CFTR~inh~-172 (20 μM, mucosal) had no effect (PGE~2~: 5.84 ± 1.20 *vs*. CFTR~inh~-172: 5.47 ± 1.39 μA/cm^2^, P \> 0.05, n = 5), but ATP (500 μM, mucosal) did stimulate an increase in *I*~*sc*~ ([Fig 3B](#pone.0189894.g003){ref-type="fig"}). Thus, in bronchial epithelial cells, PGE~2~-stimulates transepithelial Cl^-^ secretion that is entirely CFTR-dependent ([Fig 3C](#pone.0189894.g003){ref-type="fig"}). Similar experiments were performed in the normal bronchial epithelial cell line 16HBE14o-, primary human bronchial epithelial cultures, and nasal cultures from CF patients, with similar responses to that in CFBE41 WT and CF cells ([Fig 3D--3F](#pone.0189894.g003){ref-type="fig"}), confirming that this was not a cell line-specific phenomenon.

![In human bronchial epithelial cells, PGE~2~ stimulated Cl^-^ secretion is completely CFTR dependent.\
**A.** Representative *I*~*sc*~ trace with vertical deflections indicating the change in *I*~*sc*~ after a 1 mV pulse was applied (every 1 minute). Bronchial epithelial cells were exposed to serosal to mucosal Cl^-^ gradient with equivalent bilateral HCO~3~^-^. PGE~2~ (1 μM, serosal) was added to HBE41 WT cells after a baseline period of ≥ 10 minutes, with CFTR~inh~-172 (20 μM, mucosal) added afterwards. To verify cell viability, ATP (500 μM, mucosal) was added. **B.** Representative *I*~*sc*~ trace from a similar experiment with CFBE41 CF cells. **C.** Change in PGE~2~-stimulated *I*~*sc*~ (mean ± SEM, n ≥ 4) in CFBE41 WT and CF cells. Asterisks denote significance by Student's t-test (\*\*\*, P \< 0.001). Mean percent inhibition compared to CFBE41 WT noted. **D-F.** PGE~2~ stimulated Cl^-^ secretion in 16HBE14o- cells (D), primary cultures of human bronchial epithelial cells (E), and primary cultures from CF nasal polyp extract (F). Experiments were performed in the same manner as Fig 3A and representative *I*~*sc*~ traces are shown. N ≥ 3 experiments were performed for each set of cells with similar responses.](pone.0189894.g003){#pone.0189894.g003}

To examine PGE~2~-stimulated Cl^-^ secretion in serous gland cells, we used the Calu-3 cell line as a model. Experiments were performed in a similar manner as those done with bronchial epithelial cells. In the presence of amiloride (10 μM, mucosal), PGE~2~ (1 μM, serosal) stimulated a rapid and large transient increase in *I*~*sc*~, followed by a sustained significant increase in *I*~*sc*~ over baseline (17.61 ± 4.67 *vs*. 148.95 ± 18.51 μA/cm^2^, P \< 0.001, n = 8). Subsequent addition of CFTR~inh~-172 (20 μM, mucosal) caused a robust, but incomplete, inhibition of PGE~2~-stimulated *I*~*sc*~ (PGE~2~: 148.95 ± 18.51 *vs*. CFTR~inh~-172: 53.90 ± 11.70 μA/cm^2^, P \< 0.001, n = 8) ([Fig 4A and 4C](#pone.0189894.g004){ref-type="fig"}). Subsequent addition of bumetanide (10 μM, serosal), nearly eliminated the remaining PGE~2~-stimulated *I*~*sc*~ (8.15 ± 3.31 ΔμA/cm^2^ from baseline, n = 8), inhibiting PGE~2~-stimulated current by 94 ± 2%. Given the residual Cl^-^ current not inhibited by CFTR~inh~-172, we performed similar experiments to that done in ferret trachea and examined if NFA could inhibit this bumetanide-sensitive current. In the presence of CFTR~inh~-172 (20 μM, mucosal), NFA significantly inhibited PGE~2~-stimulated *I*~*sc*~ (PGE~2~+CFTR~inh~-172: 79.37 ± 16.57 *vs*. NFA: 38.40 ± 9.68 μA/cm^2^, P \< 0.05, n = 4) ([Fig 4B](#pone.0189894.g004){ref-type="fig"}). Thus, similar to bronchial epithelial cells, PGE~2~ stimulates Cl^-^ secretion in Calu-3 cells, however, in contrast to bronchial epithelial cells, this current is not completely CFTR-dependent. Similar to what is seen in ferret trachea, CFTR-independent PGE~2~-stimulated Cl^-^ secretion is predominantly NFA-sensitive ([Fig 4C](#pone.0189894.g004){ref-type="fig"}).

![In Calu-3 cells, PGE~2~ stimulated Cl^-^ secretion is mediated by CFTR and Ca^2+^-activated Cl^-^ channels.\
**A.** Representative *I*~*sc*~ trace with vertical deflections indicating the change in *I*~*sc*~ after a 1 mV pulse was applied (every 1 minute). Calu-3 cells were exposed to serosal to mucosal Cl^-^ gradient with equivalent bilateral HCO~3~^-^. PGE~2~ (1 μM, serosal) was added to Calu-3 cells after a baseline period of ≥ 10 minutes, with CFTR~inh~-172 (20 μM, mucosal) added after 30 minutes. **B.** Representative *I*~*sc*~ trace of Calu-3 cells incubated in CFTR~inh~-172 (20 μM, mucosal) for at least 30 minutes prior to PGE~2~ (1 μM, serosal) stimulation. After 30 minutes, niflumic acid (100 μM, mucosal) was added. **C.** Change in PGE~2~-stimulated *I*~*sc*~ (mean ± SEM, n ≥ 4) in Calu-3 cells, with comparisons between no inhibition, CFTR inhibition, or CFTR and Ca^2+^-activated Cl^-^ inhibition. Asterisks denote significance by Student's t-test (\*, P \< 0.05). Mean percent inhibition compared to PGE~2~ stimulation alone noted.](pone.0189894.g004){#pone.0189894.g004}

HCO~3~^-^ secretion {#sec018}
-------------------

Having evaluated the effect of PGE~2~ on airway Cl^-^ secretion, we next sought to determine if PGE~2~ also stimulates airway HCO~3~^-^ secretion. To do so, we used the same human bronchial epithelial (CFBE41 WT and CF) and serous gland (Calu-3) cell models, and measured PGE~2~-stimulated *I*~*sc*~ with a serosal to mucosal HCO~3~^-^ gradient and symmetrical Cl^-^, in the presence of amiloride (10 μM, mucosal). In this configuration, PGE~2~ (1 μM, serosal) stimulated a significant increase in *I*~*sc*~ over baseline in CFBE41 WT cells (0.53 ± 0.05 *vs*. 11.13 ± 1.87 μA/cm^2^, P \< 0.05, n = 3). Addition of CFTR~inh~-172 (20 μM, mucosal) abolished this response with *I*~*sc*~ returning to baseline levels (8.79 ± 2.003 *vs*. 0.57 ± 0.08 μA/cm^2^, P \< 0.05, n = 3) ([Fig 5A](#pone.0189894.g005){ref-type="fig"}). PGE~2~ (1 μM, serosal) failed to stimulate *I*~*sc*~ in CFBE41 CF cells ([Fig 5B](#pone.0189894.g005){ref-type="fig"}), further supporting that the PGE~2~-stimulated HCO~3~^-^ conductance in bronchial epithelial cells relies on CFTR. Since this set-up contains both Cl^-^ and HCO~3~^-^ anions that can contribute to *I*~*sc*~, we next examined if PGE~2~-stimulated increases in *I*~*sc*~ were from HCO~3~^-^ or Cl^-^. To do so we performed identical experiments in HCO~3~^-^ free conditions with acetazolamide (300 μM, serosal) and 100% O~2~ mucosal gassing. In HCO~3~^-^ free conditions, PGE~2~ failed to increase *I*~*sc*~ above baseline (0.26 ± 0.15 *vs*. 0.65 ± 0.27 μA/cm^2^, P \> 0.05, n = 3) ([Fig 5C](#pone.0189894.g005){ref-type="fig"}). These studies indicate that in CFBE41 WT cells, PGE~2~ stimulates HCO~3~^-^ transport that, similar to Cl^-^ transport in these cells, is entirely CFTR-dependent ([Fig 5D](#pone.0189894.g005){ref-type="fig"}).

![In CFBE41 cells, PGE~2~ stimulated HCO~3~^-^ secretion is completely CFTR dependent.\
**A.** Representative *I*~*sc*~ trace with vertical deflections indicating the change in *I*~*sc*~ after a 1 mV pulse was applied (every 1 minute). CFBE41 WT cells were exposed to serosal to mucosal HCO~3~^-^ gradient with equivalent bilateral Cl^-^. PGE~2~ (1 μM, serosal) was added to CFBE41 WT cells after a baseline period of ≥ 10 minutes, with CFTR~inh~-172 (20 μM, mucosal) added afterwards. **B.** Representative *I*~*sc*~ trace from a similar experiment with CFBE41 CF cells. To verify cell viability, ATP (500 μM, mucosal) was added. **C.** Representative *I*~*sc*~ trace from a similar experiment as Fig 5A with CFBE41 WT cells, except experiments were performed in HCO~3~^-^-free conditions. **D.** Change in PGE~2~-stimulated *I*~*sc*~ (mean ± SEM, n = 3) in CFBE41 WT and CF cells in HCO~3~^-^ containing and HCO~3~^-^-free conditions. Asterisks denote significance by Student's t-test (\*\*, P \< 0.01). Mean percent inhibition compared to CFBE41 WT noted.](pone.0189894.g005){#pone.0189894.g005}

We next examined PGE~2~-stimulated HCO~3~^-^ secretion in Calu-3 cells. We first performed *I*~*sc*~ measurements in Ussing chambers, similar to that done with CFBE41 cells. Under these circumstances PGE~2~ caused a large, transient increase in *I*~*sc*~, followed by a sustained significant increase in *I*~*sc*~ (21.00 ± 2.30 *vs*. 51.22 ± 2.43 μA/cm^2^, P \< 0.001, n = 7), which was markedly decreased (31%), but not completely eliminated by CFTR inhibition with CFTR~inh~-172 (51.22 ± 2.43 *vs*. 42.24 ± 1.53 μA/cm^2^, P \< 0.01, n = 7) ([Fig 6A and 6C](#pone.0189894.g006){ref-type="fig"}). When repeating these experiments in HCO~3~^-^- free conditions, there remained a residual anion current stimulated by PGE~2~ (51.22 ± 2.43 *vs*. 42.24 ± 1.53 μA/cm^2^, P \< 0.01, n = 7) that was resistant to CFTR~inh~-172 ([Fig 6B and 6C](#pone.0189894.g006){ref-type="fig"}). Given our prior findings suggesting that PGE~2~ can stimulate a Ca^2+^-activated Cl^-^ channel current in Calu-3 cells, we employed the pH-stat technique to measure HCO~3~^-^ secretion in a more direct manner. With this method, voltage clamp and pH-stat were simultaneously measured with Calu-3 cells exposed to symmetrical Cl^-^ and a serosal to mucosal HCO~3~^-^ gradient with mucosal O~2~ gassing to prevent the generation of apical base from gassed CO~2~. To mitigate any potential influences of drugs on apical pH, these experiments were performed with DMSO (5 μL; 1:1000 with bath) or CFTR~inh~-172 (20 μM, mucosal) added prior to PGE~2~ stimulation. With this method, PGE~2~-stimulated a significant increase in HCO~3~^-^ secretion in control conditions (n = 10, P \> 0.05). In contrast, CFTR inhibition ameliorated this response (n = 6, P \< 0.05) ([Fig 6D](#pone.0189894.g006){ref-type="fig"}). Similar to prior experiments, PGE~2~-stimulated a significant increase in *I*~*sc*~, that was partially inhibited with CFTR~inh~-172 (P \< 0.05) ([Fig 6E](#pone.0189894.g006){ref-type="fig"}). To ensure that activation of apical non-gastric H^+^/K^+^ ATPase did not cause falsely low HCO~3~^-^ secretory rates, we performed similar experiments with or without apical ouabain (10 μM). Oubain did not significantly alter PGE~2~-stimulated HCO~3~^-^ secretion, with or without CFTR~inh~-172 (n ≥ 5, P \> 0.05) ([Fig 7](#pone.0189894.g007){ref-type="fig"}).

![In Calu-3 cells, PGE~2~ stimulated HCO~3~^-^ secretion is completely CFTR dependent.\
**A.** Representative *I*~*sc*~ trace with vertical deflections indicating the change in *I*~*sc*~ after a 1 mV pulse was applied (every 1 minute). Calu-3 cells were exposed to serosal to mucosal HCO~3~^-^ gradient with equivalent bilateral Cl^-^. PGE~2~ (1 μM, serosal) was added to Calu-3 cells after a baseline period of ≥ 10 minutes, with CFTR~inh~-172 (20 μM, mucosal) added 30 minutes after. **B.** Representative *I*~*sc*~ trace from a similar experiment with Calu-3 cells in HCO~3~^-^-free conditions. **C.** Change in PGE~2~-stimulated *I*~*sc*~ (mean ± SEM, n = 3) in Calu-3 cells, with comparisons between no inhibition, CFTR inhibition, and HCO~3~^-^-free conditions. Asterisks denote significance by Student's t-test (\*\*, P \< 0.01, \*\*\*, P \< 0.001). Mean percent inhibition compared to Calu-3 cells under control conditions. **D.** Timecourse of HCO~3~^-^ secretion measured by pH-stat. The serosal solution was bathed with 95% O~2~/5% CO~2~ (similar to experiments in A-C), but the mucosal solution was bathed with 100% O~2~ to prevent base formation from carbonhic anhydrase conversion of CO~2~. Calu-3 cells were incubated in DMSO (5 μL; 1:1000 with bath; n = 10) or CFTR~inh~-172 (20 μM, mucosal; n = 6) for 30--60 minutes prior to PGE~2~ stimulation (1 μM, serosal). Circles represent means with bars indicating SEM. Asterisks represent P \< 0.05 by ANOVA. **E.** Timecourse of *I*~*sc*~ measured by pH-stat measured simultaneously as pH-stat. Circles represent means with bars indicating SEM. Asterisks represent P \< 0.05 by ANOVA.](pone.0189894.g006){#pone.0189894.g006}

![In Calu-3 cells, PGE~2~ stimulated HCO~3~^-^ secretion is not affected by apical oubain, an inhibitor of the non-gastric H^+^/K^+^ ATPase.\
Experiments were performed to determine the potential role of ATP12A in measured PGE~2~-stimulated HCO~3~^-^ secretion in normal and CF conditions. Calu-3 experiments were performed similar to that in [Fig 6](#pone.0189894.g006){ref-type="fig"}, with the exception that an additional set of experiments were done with oubain (10 μM, mucosal) pre-treatment for ≥ 40 minutes prior to PGE~2~ stimulation. Bars represent change in PGE~2~-stimulated *I*~*sc*~ (mean ± SEM, n ≥ 5) in Calu-3 cells. Statistical comparisons were done between PGE~2~ with and without oubain and PGE~2~ with CFTR inhibition with and without oubain. No statistical difference was noted in either case (P \> 0.05 by Student's t-test).](pone.0189894.g007){#pone.0189894.g007}

Discussion {#sec019}
==========

PGE~2~ and CF airway disease {#sec020}
----------------------------

Cystic fibrosis affects approximately 30,000 people in the U.S., with an estimated annual mean healthcare cost of approximately 1.5 Billion U.S. dollars \[[@pone.0189894.ref025]\]. The majority of healthcare costs, morbidity, and mortality associated with CF are attributed to pulmonary infections and their associated complications. Amongst the inflammatory milieu of the infected airways, PGE~2~ is abundantly produced by epithelia and infiltrating inflammatory cells, and is found in bronchioalveolar lavage fluid, sputum, and airway epithelium \[[@pone.0189894.ref007]--[@pone.0189894.ref010]\]. Lack of functional CFTR may tilt the balance into excessive PGE~2~ production, leading to a positive proinflammatory loop of NF-kβ (nuclear factor-kappa beta) and CREB (cAMP response element binding protein) activation, causing an upregulation of cyclooxygenase-2 (COX-2) and increased PGE~2~ production \[[@pone.0189894.ref026]\]. The overall result being an exaggerated inflammatory condition. Ibuprofen, which can be a useful therapeutic agent in CF \[[@pone.0189894.ref027]\], may help tip the balance of PGE~2~ back to appropriate levels. In addition to promoting inflammation, PGE~2~ also helps resolve inflammation by stimulating Cl^-^, HCO~3~^-^, and mucin secretion \[[@pone.0189894.ref011]\]. Bronchotracheal MCC is integral to the innate mucosal defense against microbial insults and is regulated by coordinated efforts between transepithelial Cl^-^ secretion and submucosal gland mucus secretion. In this study, we have shown for the first time that PGE~2~ stimulates MCC in ferret trachea. We also showed that CFTR inhibition causes a significant decrease (\~50%) in the initial phase of MCC, indicating that PGE~2~-stimulated MCC in CF patients may be impaired. The inability of CFTR~inh~-172 to have a more substantial impact on MCC may be related to the activation of non-CFTR Cl^-^ channels, supported by the ability of niflumic acid to further inhibit CFTR~inh~-172-independent *I*~*sc*~, or relative insensitivity of ferret CFTR channels to CFTR~inh~-172 \[[@pone.0189894.ref028]\]. The former hypothesis is supported by our Calu-3 data, which also showed sensitivity to both CFTR~inh~-172 and niflumic acid. Activation of TMEM16A channels increases ciliary beat frequency and ASL height, both of which would increase MCC \[[@pone.0189894.ref029]\]. Likewise, Joo *et al*. found that in the ferret trachea forskolin-, but not carbachol-stimulated MCC was inhibited by CFTR~inh~-172 \[[@pone.0189894.ref030]\]. Thus, we speculate that the residual PGE~2~-induced MCC during CFTR inhibition may be due to Ca^2+^-activated Cl^-^ channel activity.

Chloride secretion {#sec021}
------------------

We are not the first group to examine PGE~2~-stimulated anion transport in the airway, however, we have undertaken the most comprehensive examination of PGE~2~-stimulated Cl^-^ and HCO~3~^-^ secretion to date. Cullen and Widdicombe *et al*. showed that PGE~2~ increases *I*~*sc*~ in canine and human trachea \[[@pone.0189894.ref015], [@pone.0189894.ref031]\], while Cowley showed the same in Calu-3 cells \[[@pone.0189894.ref032]\]. In the latter study, PGE~2~-stimulated *I*~*sc*~ was inhibited 87% by pre-incubation with DPC (diphenylamine-2-carboxylate), suggesting significant CFTR-dependence \[[@pone.0189894.ref032]\]. Before newer generation CFTR inhibitors, DPC was commonly used to inhibit CFTR. However, DPC is not specific for CFTR and can inhibit other Cl^-^ channels \[[@pone.0189894.ref033]\]. In our bronchial epithelial experiments, we found that CFTR~inh~-172 was a potent and complete inhibitor of PGE~2~-stimulated Cl^-^ secretion. As such, we speculate that the CFTR~inh~-172-independent *I*~*sc*~ observed in ferret trachea and Calu-3 cells is due to non-CFTR Cl^-^ channels. Widdicombe et al. observed small increases in PGE~2~-stimulated *I*~*sc*~ in CF human trachea that was unresponsive to isoproterenol \[[@pone.0189894.ref031]\]. With the ability of niflumic acid to inhibit our observed residual current, we hypothesize that Ca^2+^-activated Cl^-^ channels account for the CFTR~inh~-172-independent *I*~*sc*~ in ferret trachea and Calu-3 cells. Shamsuddin *et al* found that complete inhibition of PGE~2~-stimulated *I*~*sc*~ in small porcine airways required both CFTR and Ca^2+^-activated channel inhibition (GlyH-101 and niflumic acid, respectively) \[[@pone.0189894.ref016]\].

We found differential responses to PGE~2~-stimulated Cl^-^ secretion between bronchial epithelial cell lines and submucosal gland cell lines. In WT CFBE41 and other bronchial epithelial cell lines (including primary culture), PGE~2~-stimulated Cl^-^ secretion required CFTR. However, Calu-3 cells appear to utilize both CFTR and Ca^2+^-activated Cl^-^ channels. Ferret trachea showed similar responses to Calu-3 cells, likely due to the presence of submucosal glands. The difference in responses is unlikely to be due to a lack of Ca^2+^-activated Cl^-^ channels in our bronchial epithelial cell cultures since apical ATP stimulated Cl^-^ current in both WT and CFBE41 cells. It is possible that there is differential PGE~2~ receptor expression between the two cell types. Four different receptors for PGE~2~ have been described (EP~1~-EP~4~), with all four being expressed in Calu-3 cells. EP~1~ and EP~2~ receptors are located at the apical membrane, while EP~3~ and EP~4~ receptors are located at both the apical and basolateral membranes \[[@pone.0189894.ref017]\]. In normal human tracheobronchial epithelial (NHTBE) cells, EP~1~-EP~4~ mRNA are present \[[@pone.0189894.ref034]\], however, to our knowledge, there are no published reports examining EP receptor membrane expression in CFBE41o- cells or other surface airway epithelial cells. EP~1~ and EP~3~ signaling increases intracellular Ca^2+^, while EP~3~ can also stimulate inositol triphosphate (IP~3~). EP~2~ and EP~4~ increase cAMP, while EP~4~ also stimulates PI3K \[[@pone.0189894.ref035]\]. In the duodenum, PGE~2~ stimulates HCO~3~^-^ secretion *via* cAMP, Ca^2+^, and PI3K through EP~3~ and EP~4~ receptors \[[@pone.0189894.ref012]\]. In Calu-3 cells, Joy *et al*. found that CFTR-dependent PGE~2~-stimulated iodide efflux was mediated by EP~4~ \[[@pone.0189894.ref017]\]. This leads one to hypothesize that CFTR-dependent Cl^-^ secretion in bronchial epithelial cells and Calu-3 cells may be mediated by EP~4~, whereas Ca^2+^-activated Cl^-^ secretion in Calu-3 cells may occur through EP~3~ activation. Ongoing studies examining the EP receptor membrane distribution in bronchial epithelial cells may shed light on this hypothesis ([Fig 8](#pone.0189894.g008){ref-type="fig"}). It may also be possible that there is different intracellular signaling machinery in bronchial epithelial cells and Calu-3 cells, leading to cAMP and Ca^2+^ crosstalk in Calu-3, but not, bronchial epithelial cells. In mouse inner medullary collecting duct cells, PGE~2~ stimulated CFTR~inh~-172- and flufenamic acid-sensitive *I*~*sc*~ exclusively through EP~4~ receptors. Inhibition of IP~3~ receptors with 2-APB (aminoethoxyldiphenyl borate) blocked PGE~2~-stimulated *I*~*sc*~ by nearly 80%, with complete inhibition of the Ca^2+^-activated Cl^-^ current. \[[@pone.0189894.ref036]\]. Lee *et al*. have described cAMP-dependent activation of IP~3~-dependent Ca^2+^ release in submucosal glands and Joo *et al*. have recently shown that low dose forskolin and carbachol can generate a synergistic *I*~*sc*~ and MCC response in ferret trachea \[[@pone.0189894.ref030], [@pone.0189894.ref037]\]. Intracellular increases in cAMP may bind to Epac (exchange protein directly activated by cAMP), catalyzing the generation of IP~3~ by phospholipase C, resulting in release of intracellular Ca^2+^ stores and eventual Ca^2+-^activated Cl^-^ channel activation \[[@pone.0189894.ref038], [@pone.0189894.ref039]\]. Namkung *et al*. also showed that elevations in intracellular Ca^2+^ can also lead to activation of Ca^2+^/calmodulin-sensitive adenylyl cyclase 1, further illustrating the possible bidirectional activation of cAMP and Ca^2+^ signaling pathways \[[@pone.0189894.ref040]\]. In the intestine, lubiprostone, a prostaglandin derivative, increases the trafficking of EP~4~ and CFTR to the membrane, which would be anticipated to increase ion transport \[[@pone.0189894.ref041]\]. It is unclear if a similar mechanism occurs in bronchial epithelial cells or submucosal glands when exposed to PGE~2~. Ongoing research into the receptor dependence of PGE~2~ stimulation in bronchial epithelial cells and submucosal glands, and the intracellular signaling and trafficking involved in Ca^2+^-activated Cl^-^ channel activation may lead to new ideas on how to coopt this mechanism as a therapeutic target in CF.

![Simplified working model of PGE~2~-stimulated Cl^-^ and HCO~3~^-^ secretion and mucociliary clearance in non-CF and CF airway.\
**A.** In the airway, microbial infections cause an increase in PGE~2~ through release from infiltrating inflammatory cells (not pictured) and production by airway epithelia *via* COX-2 activation. H~2~O~2~ produced by DUOX activates COX-2 and HVCN1 channels provide the H^+^ shunt from H~2~O~2~ production. PGE~2~ exits the cell and activates PGE~2~ (EP) receptors. In the current study we did not examine specific EP receptor involvement, however, we propose that EP~4~ is the predominant mediator of serosal PGE~2~ stimulation in bronchial epithelial cells. Submucosal gland cells may also utilize the EP~3~ receptor, or Ca^2+^-activated Cl^-^ channels (CaCC) may get activated *via* EP~4~-mediated cAMP-Ca^2+^ crosstalk. In bronchial epithelial cells, PGE~2~ stimulates Cl^-^ and HCO~3~^-^ secretion *via* CFTR, whereas in submucosal glands, both CFTR and CaCC are activated. Cl^-^ and HCO~3~^-^ secretion will then influence airway pH, mucus properties, hydration, and ultimately, mucociliary clearance. **B.** In CF airway, lack of CFTR-dependent Cl^-^ and HCO~3~^-^ secretion in bronchial epithelial cells, coupled with no HCO~3~^-^ secretion and decreased Cl^-^ secretion from submucosal glands, leads to an acidic airway pH, thick-adherent mucus, and decreased mucociliary clearance. This results in increased microbial infection and rampant inflammation, in part by increased PGE~2~ production.](pone.0189894.g008){#pone.0189894.g008}

Bicarbonate secretion {#sec022}
---------------------

In recent years there has been increased focus on airway HCO~3~^-^ transport, as it has become apparent that defective ASL formation cannot be accounted for by altered Cl^-^ and Na^+^ alone \[[@pone.0189894.ref042]--[@pone.0189894.ref044]\]. The role of HCO~3~^-^ secretion in MCC is less clear than that of Na^+^ or Cl^-^. Jeong *et al*. found that HCO~3~^-^ removal did not decrease MCC in a statistically significant manner \[[@pone.0189894.ref002]\]. However, HCO~3~^-^ removal impairs submucosal gland secretion and mucus detachment, both of which would negatively affect MCC \[[@pone.0189894.ref045], [@pone.0189894.ref046]\]. Airway HCO~3~^-^ secretion has been confirmed previously in both surface epithelial cells and submucosal glands \[[@pone.0189894.ref044], [@pone.0189894.ref047]\]. Shamsuddin *et al*. showed that PGE~2~ stimulates HCO~3~^-^ transport in porcine small airways \[[@pone.0189894.ref016]\], but we are the first to examine PGE~2~-stimulated HCO~3~^-^ secretion in both bronchial epithelial and Calu-3 cells. In addition to CFTR, HCO~3~^-^ conductance can be regulated through increased HCO~3~^-^ uptake by the Na:HCO~3~^-^ cotransporter, basolateral Cl^-^/HCO~3~^-^ exchange and/or intracellular HCO~3~^-^ generation by carbonic anhydrase. In the current study, we did not examine the individual roles of these processes in generating HCO~3~^-^ substrate, however, we did show that PGE~2~-stimulated HCO~3~^-^ secretion in the airway requires CFTR. This may occur through direct HCO~3~^-^ transport through CFTR and/or apical recycling of CFTR-mediated Cl^-^ secretion through apical Cl^-^/HCO~3~^-^ anion exchangers \[[@pone.0189894.ref019], [@pone.0189894.ref048]\]. In the duodenum, apical HCO~3~^-^ conductance through Cl^-^/HCO~3~^-^ exchangers can occur in an electroneutral manner, independent of CFTR \[[@pone.0189894.ref013]\]. Our pH-stat data did not show any electroneutral HCO~3~^-^ secretion, indicating that, in contrast to the duodenum \[[@pone.0189894.ref013]\], CFTR-independent Cl^-^/HCO~3~^-^ exchange is likely not involved in PGE~2~-stimulated HCO~3~^-^ secretion in Calu-3 cells.

It remains unclear whether the effects of HCO~3~^-^ transport loss in CF are due to acidic pH or HCO~3~^-^ itself. To address this question, Tang *et al*. examined CF porcine ASL viscosity at variable HCO~3~^-^ concentrations and pH values. In their experiments, ASL viscosity was primarily affected by pH, not HCO~3~^-^ concentration itself \[[@pone.0189894.ref003]\]. In addition to HCO~3~^-^ transport, H^+^ secretion also helps to regulate ASL pH. Lung epithelium contains DUOX NADPH oxidase, which produces H~2~O~2~ for release during pulmonary microbial infections. Schwarzer *et al*. showed that Zn^2+^-sensitive HVCN1 channels shunt H^+^ generated during DUOX NADPH oxidase reactions out of the cell \[[@pone.0189894.ref049]\]. This would serve to lower ASL pH. Interestingly, H~2~O~2~ causes autocrine release of PGE~2~ and stimulates CFTR-dependent increases in *I*~*sc*~ \[[@pone.0189894.ref050]\]. Thus, one might hypothesize that H~2~O~2~ release during acute pulmonary infections may increase PGE~2~-stimulated Cl^-^ secretion to increase MCC and increase HCO~3~^-^ secretion to limit the negative effect of H~2~O~2~-induced H^+^ secretion on ASL pH ([Fig 8](#pone.0189894.g008){ref-type="fig"}). Iovannisci *et al*. also showed that HVCN1 H^+^ channels are activated by ASL pH, being closed at resting ASL pH of 6.85 and become active as the pH alkalinizes above that \[[@pone.0189894.ref023]\]. In our *I*~*sc*~ experiments we did not examine H^+^ secretion specifically. These experiments were done at pH 7.4 so in theory the HVCN1 H^+^ channel could be active. The lack of *I*~*sc*~ response to PGE~2~ in bronchial epithelial cells without CFTR or with HCO~3~^-^ removal suggests that HVCN1 H^+^ channels were either not activated by PGE~2~ or they play an insignificant role. Likewise, our pH-stat experiments were performed at a set point of pH 6.9 to ensure that HVCN1 activation did not mask HCO~3~^-^ secretion. Another potential contributor to apical H^+^ transport and ASL pH in porcine and human airway epithelium is ATP12A (the α subunit of non-gastric H^+^/K^+^ ATPase). Shah *et al*. showed that at pH 7.0, in CF human and pig airway epithelia, cAMP stimulated a decrease in ASL pH, which was inhibited by apical oubain or siRNA against ATP12A \[[@pone.0189894.ref051]\]. Thus, it has been proposed that in the absence of CFTR, increases in cAMP may lead to ATP12A activation and acidify the ASL. In our bronchial epithelial studies, similar to the reasons stated above, we did not examine ATP12A channel activation. However, we did perform a set of experiments in Calu-3 cells with pH-stat where we applied apical oubain to determine if this unmasked a change in PGE~2~-stimulated apical pH. We found no change with or without ouabain, leading us to conclude that in Calu-3 cells, under our experimental conditions, PGE~2~ does not activate ATP12A channels. Altogether, we do not have any evidence that PGE~2~ activates HVCN1 or ATP12A channels, although specific studies examining PGE~2~-stimulated H^+^ secretion in different pH environments may be warranted. What we can say is that PGE~2~ does stimulate HCO~3~^-^ secretion in bronchial epithelial cells and submucosal glands and we propose that together with Cl^-^ secretion, this contributes to increasing MCC and microbial removal during infection.

Conclusions {#sec023}
-----------

In summary, we have shown that PGE~2~, an inflammatory mediator produced during CF pulmonary exacerbations, is involved in bronchotracheal MCC and the stimulation of Cl^-^ and HCO~3~^-^ secretion from bronchial epithelial cells and submucosal glands. Absence of CFTR activity in bronchial epithelial cells leads to a total loss of both Cl^-^ and HCO~3~^-^ secretion. In submucosal glands, HCO~3~^-^ secretion is absent, yet some niflumic acid-sensitive Cl^-^ secretion remains, suggesting involvement of Ca^2+^-activated Cl^-^ secretion. This residual anion current may mitigate some of the deleterious effects of CFTR loss on MCC. These studies provide further information on the role of CFTR in maintaining airway health and provide additional insight into CF airway pathology. Further work to understand the mechanism whereby PGE~2~ may stimulate Ca^2+^-activated Cl^-^ channels and MCC in CF, may help identify new therapeutic targets that may assist in the normalization of airway ion transport and clearance of pulmonary microbial insults.
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